Cordant announced a study published in the Journal of Substance Abuse Treatment, which demonstrated that patients using Cordant’s managed medication-assisted treatment (MAT) pharmacy program had higher retention rates, fewer opiate-positive lab tests, and fewer drug-related emergency department visits. 100% of the patient respondents reported they would recommend Cordant’s pharmacy program.

Presented by Elizabeth Kolb, Cordant Senior Director of Corporate Development & Strategy and co-author of the study.

The full-length article is available on the Journal of Substance Abuse website https://www.journalofsubstanceabusetr...